Sign in
Groups
Researchers
Results
MANUEL
DELGADO ALVARADO
Researcher to 2022
Instituto de Salud Carlos III
Madrid, España
You are in
Collaborations
Instituto de Salud Carlos III
Publications in collaboration with researchers from Instituto de Salud Carlos III (1)
2023
Switch to ocrelizumab in MS patients treated with natalizumab in extended interval dosing at high risk of PML: A 96-week follow-up pilot study
Frontiers in Immunology, Vol. 14
Contact
Legal notice
Help
translate
en
arrow_drop_down
translate
en
arrow_drop_down
es
eu
fr
de